SE444946B - Peptider, som inhiberar frigorandet av steroider - Google Patents

Peptider, som inhiberar frigorandet av steroider

Info

Publication number: SE444946B
Authority: SE; Sweden
Prior art keywords: trp; pro; leu; peptides; peptide
Prior art date: 1977-11-30

Application number

SE7812255A

Other languages

English (en)

Swedish (sv)

Other versions

SE7812255L (sv

Inventor

C L Rivier

J E F Rivier

Jr W W Vale

Original Assignee

Salk Inst For Biological Studi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-11-30

Filing date

1978-11-28

Publication date

1986-05-20

1978-10-16 Priority claimed from US05/950,301 external-priority patent/US4215038A/en

1978-11-28 Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi

1979-05-31 Publication of SE7812255L publication Critical patent/SE7812255L/xx

1986-05-20 Publication of SE444946B publication Critical patent/SE444946B/sv

Links

108090000765 processed proteins & peptides Proteins 0.000 title claims description 73
150000003431 steroids Chemical class 0.000 title claims description 4
102000004196 processed proteins & peptides Human genes 0.000 title description 34
230000002401 inhibitory effect Effects 0.000 title description 5
QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 40
COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical group OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims description 20
102000006771 Gonadotropins Human genes 0.000 claims description 8
108010086677 Gonadotropins Proteins 0.000 claims description 8
239000002622 gonadotropin Substances 0.000 claims description 8
HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 claims description 7
229940094892 gonadotropins Drugs 0.000 claims description 7
ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 claims description 4
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 claims description 4
ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims description 3
OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical group OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 claims description 2
125000002698 D-tryptophano group Chemical group C(=O)(O)[C@@H](CC1=CNC2=CC=CC=C12)N* 0.000 claims 3
125000001711 D-phenylalanine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
229920005989 resin Polymers 0.000 description 36
239000011347 resin Substances 0.000 description 36
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 26
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 21
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 20
125000006239 protecting group Chemical group 0.000 description 17
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
241000700159 Rattus Species 0.000 description 14
150000001413 amino acids Chemical class 0.000 description 13
230000016087 ovulation Effects 0.000 description 12
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 11
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 10
241000124008 Mammalia Species 0.000 description 10
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 10
239000000460 chlorine Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 7
-1 Arg Chemical class 0.000 description 6
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
238000000034 method Methods 0.000 description 6
QPJSUIGXIBEQAC-UHFFFAOYSA-N n-(2,4-dichloro-5-propan-2-yloxyphenyl)acetamide Chemical compound CC(C)OC1=CC(NC(C)=O)=C(Cl)C=C1Cl QPJSUIGXIBEQAC-UHFFFAOYSA-N 0.000 description 6
230000028327 secretion Effects 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 5
102000009151 Luteinizing Hormone Human genes 0.000 description 5
108010073521 Luteinizing Hormone Proteins 0.000 description 5
125000003277 amino group Chemical group 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 5
239000000543 intermediate Substances 0.000 description 5
229940040129 luteinizing hormone Drugs 0.000 description 5
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
206010062767 Hypophysitis Diseases 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
230000012173 estrus Effects 0.000 description 4
229940088597 hormone Drugs 0.000 description 4
239000005556 hormone Substances 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
238000006386 neutralization reaction Methods 0.000 description 4
210000003635 pituitary gland Anatomy 0.000 description 4
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
238000005727 Friedel-Crafts reaction Methods 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
230000008878 coupling Effects 0.000 description 3
238000010168 coupling process Methods 0.000 description 3
235000013601 eggs Nutrition 0.000 description 3
238000004810 partition chromatography Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000026234 pro-estrus Effects 0.000 description 3
230000007017 scission Effects 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical group C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 2
150000008574 D-amino acids Chemical class 0.000 description 2
125000003941 D-tryptophan group Chemical group [H]C1=C([H])C([H])=C2C(C([C@@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000037396 body weight Effects 0.000 description 2
HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
239000003433 contraceptive agent Substances 0.000 description 2
235000021186 dishes Nutrition 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000010828 elution Methods 0.000 description 2
238000001914 filtration Methods 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
210000002149 gonad Anatomy 0.000 description 2
239000000601 hypothalamic hormone Substances 0.000 description 2
229940043650 hypothalamic hormone Drugs 0.000 description 2
210000003016 hypothalamus Anatomy 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
230000001817 pituitary effect Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 description 1
WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 1
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
102000015611 Hypothalamic Hormones Human genes 0.000 description 1
108010024118 Hypothalamic Hormones Proteins 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
150000003973 alkyl amines Chemical group 0.000 description 1
238000005576 amination reaction Methods 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
238000007098 aminolysis reaction Methods 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
229940073608 benzyl chloride Drugs 0.000 description 1
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
229940124558 contraceptive agent Drugs 0.000 description 1
230000002254 contraceptive effect Effects 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
125000004185 ester group Chemical group 0.000 description 1
239000000284 extract Substances 0.000 description 1
230000007849 functional defect Effects 0.000 description 1
230000002710 gonadal effect Effects 0.000 description 1
230000001456 gonadotroph Effects 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
208000000509 infertility Diseases 0.000 description 1
230000036512 infertility Effects 0.000 description 1
231100000535 infertility Toxicity 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229910052754 neon Inorganic materials 0.000 description 1
GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
230000027758 ovulation cycle Effects 0.000 description 1
239000003415 peat Substances 0.000 description 1
229940100684 pentylamine Drugs 0.000 description 1
108010091718 peptide L Proteins 0.000 description 1
229940117803 phenethylamine Drugs 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
229920005990 polystyrene resin Polymers 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000027272 reproductive process Effects 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
239000002002 slurry Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
239000000057 synthetic resin Substances 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
108010080629 tryptophan-leucine Proteins 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

SE7812255A 1977-11-30 1978-11-28 Peptider, som inhiberar frigorandet av steroider SE444946B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US85583777A	1977-11-30	1977-11-30
US05/950,301 US4215038A (en)	1978-10-16	1978-10-16	Peptides which inhibit gonadal function

Publications (2)

Publication Number	Publication Date
SE7812255L SE7812255L (sv)	1979-05-31
SE444946B true SE444946B (sv)	1986-05-20

Family

ID=27127312

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7812255A SE444946B (sv)	1977-11-30	1978-11-28	Peptider, som inhiberar frigorandet av steroider

Country Status (9)

Country	Link
AU (1)	AU520419B2 (de)
CA (1)	CA1116594A (de)
CH (1)	CH639942A5 (de)
DE (1)	DE2851630A1 (de)
FR (1)	FR2410642A1 (de)
GB (1)	GB2009182B (de)
NL (1)	NL7811723A (de)
NZ (1)	NZ188987A (de)
SE (1)	SE444946B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4292313A (en) *	1980-04-15	1981-09-29	The Salk Institute For Biological Studies	LRF Antagonists
NZ196558A (en) *	1980-04-15	1984-10-19	Salk Inst For Biological Studi	Lrf antagonists and pharmaceutical compositions
US4409208A (en) *	1980-04-15	1983-10-11	The Salk Institute For Biological Studies	GnRH antagonists
ATE8988T1 (de) *	1980-06-02	1984-09-15	Andrew Victor Schally	Lh-rh antagonisten.
IL70888A0 (en) *	1983-03-10	1984-05-31	Salk Inst For Biological Studi	Gn rh antagonist peptides and pharmaceutical compositions containing them
US4530920A (en) *	1983-11-07	1985-07-23	Syntex (U.S.A.) Inc.	Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
US4547370A (en) *	1983-11-29	1985-10-15	The Salk Institute For Biological Studies	GnRH Antagonists
IL74827A (en) *	1984-05-21	1989-06-30	Salk Inst For Biological Studi	Peptides active as gnrh antagonists and pharmaceutical compositions containing them
US4632979A (en) *	1984-06-18	1986-12-30	Tulane Educational Fund	Therapeutic LHRH analogs
ZA862570B (en) *	1985-04-09	1986-12-30	Univ Tulane	Therapeutic decapeptides
US4866160A (en) *	1985-04-09	1989-09-12	The Administrators Of The Tulane Educational Fund	Therapeutic decapeptides
EP0225746A3 (de) *	1985-11-14	1989-12-20	The Administrators of The Tulane Educational Fund	Therapeutische Dekapeptide
DE3634435A1 (de) *	1986-10-09	1988-04-14	Hoechst Ag	Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
DE68928278T2 (de) *	1988-02-10	1998-03-12	Tap Pharmaceuticals Inc	Lhrh-analog
US5110904A (en) *	1989-08-07	1992-05-05	Abbott Laboratories	Lhrh analogs
US5084443A (en) *	1989-12-04	1992-01-28	Biomeasure, Inc.	Promoting expression of acetylcholine receptors with lhrh antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3928307A (en) *	1974-11-04	1975-12-23	American Home Prod	P-Glu-D-Phe-Trp-Ser-Tyr-D-Phee-Leu-Arg-Pro-Gly-NH2 and intermediates
US3933782A (en) *	1974-11-14	1976-01-20	American Home Products Corporation	(N-Acetyl)-Pro-D-Phe-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt and intermediates
US4089946A (en) *	1976-06-07	1978-05-16	American Home Products Corporation	Claudogenic-interceptive nonapeptides

1978
- 1978-11-22 NZ NZ188987A patent/NZ188987A/xx unknown
- 1978-11-27 AU AU41948/78A patent/AU520419B2/en not_active Expired
- 1978-11-28 SE SE7812255A patent/SE444946B/sv not_active IP Right Cessation
- 1978-11-28 CA CA000317018A patent/CA1116594A/en not_active Expired
- 1978-11-29 NL NL7811723A patent/NL7811723A/xx not_active Application Discontinuation
- 1978-11-29 DE DE19782851630 patent/DE2851630A1/de not_active Withdrawn
- 1978-11-29 FR FR7833756A patent/FR2410642A1/fr active Granted
- 1978-11-30 CH CH1225878A patent/CH639942A5/de not_active IP Right Cessation
- 1978-11-30 GB GB7846680A patent/GB2009182B/en not_active Expired

Also Published As

Publication number	Publication date
GB2009182A (en)	1979-06-13
NL7811723A (nl)	1979-06-01
CA1116594A (en)	1982-01-19
GB2009182B (en)	1982-02-24
DE2851630A1 (de)	1979-05-31
SE7812255L (sv)	1979-05-31
AU4194878A (en)	1979-06-07
AU520419B2 (en)	1982-01-28
FR2410642A1 (fr)	1979-06-29
CH639942A5 (de)	1983-12-15
FR2410642B1 (de)	1983-10-21
NZ188987A (en)	1982-02-23

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 7812255-3

Effective date: 19891120

Format of ref document f/p: F

Publication	Publication Date	Title
US4218439A (en)	1980-08-19	Peptide which inhibits gonadal function
JP2944669B2 (ja)	1999-09-06	ペプチド、その製造法、該ペプチドを含有する、ｌｈｒｈ拮抗剤
CA1154758A (en)	1983-10-04	Water-soluble peptides affecting gonadal function
KR930008095B1 (ko)	1993-08-25	Lhrh 길항제로서 유용한 lhrh의 노나펩타이드 및 데카펩타이드 동족체
EP0131007B1 (de)	1990-08-16	Gnrh-agonisten
KR900007083B1 (ko)	1990-09-28	GnRH 길항물질 제조방법
US3914412A (en)	1975-10-21	{8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
SE444946B (sv)	1986-05-20	Peptider, som inhiberar frigorandet av steroider
NO301015B1 (no)	1997-09-01	Dekapeptid med antiovulatorisk aktivitet
JP2542362B2 (ja)	1996-10-09	新規ハロ低級アルキルグアニジノ置換アミノ酸化合物およびその製法
NO324991B1 (no)	2008-01-14	GnRH antagonistpeptid samt farmasoytisk preparat inneholdende det samme.
CZ299308B6 (cs)	2008-06-11	Peptidový analog LH-RH, peptidový agonista nebo antagonista LH-RH, farmaceutický prípravek a použití peptidu pro prípravu léciva
EP0097031A2 (de)	1983-12-28	Nonapeptid- und Decapeptidanaloge von LHRH mit Wirkung als LHRH Antagonisten, ihre Herstellung und diese enthaltende Zusammensetzungen
US4215038A (en)	1980-07-29	Peptides which inhibit gonadal function
US4072668A (en)	1978-02-07	LH-RH Analogs
DK166214B (da)	1993-03-22	Gnrh-antagonistisk peptid og farmaceutisk acceptable salte heraf samt farmaceutisk praeparat indeholdende peptidet
FI82255C (fi)	1991-02-11	Foerfarande foer framstaellning av nya gonadoliberinderivat som paoverkar djurens foeroekningsprocesser.
CS228924B2 (en)	1984-05-14	Method of preparing peptides inhibiting the release of gonadotropine from mammalian hypophysis
US4382922A (en)	1983-05-10	Peptides affecting gonadal function
HU185427B (en)	1985-02-28	Process for preparing antagonists of hormone releasing luteinizing hormone
NO840880L (no)	1984-09-11	Peptid og fremgangsmaate for dets fremstilling
EP0225746A2 (de)	1987-06-16	Therapeutische Dekapeptide
CA1298683C (en)	1992-04-07	Therapeutic decapeptides
DK150206B (da)	1987-01-05	Analogifremgangsmaade til fremstilling af lrf-analoge nona- eller decapeptidamider eller ikke-toksiske salte deraf og nona- eller decapeptidderivater til anvendelse som udgangsforbindelser ved fremgangsmaaden
EP0047079B1 (de)	1984-02-22	Nonapeptide mit Wirkung auf die Funktion der Keimdrüsen